VCNX: Vaccinex, Inc. Stock

by  •  • Comments Off on VCNX: Vaccinex, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 3.77
Enterprise Value ($M) 2.43
Book Value ($M) -1.32
Book Value / Share -0.49
Price / Book -2.86
NCAV ($M) -1.42
NCAV / Share -0.53
Price / NCAV -2.66

Profitability (mra)
Return on Invested Capital (ROIC) n/a
Return on Assets (ROA) -5.12
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 0.77
Current Ratio 0.77

Balance Sheet (mrq) ($M)
Current Assets 4.76
Assets 4.85
Liabilities 6.17
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-14 13G/A Armistice Capital, Llc 4.99 -16.74
11-18 13D/A Zauderer Maurice 16.60 10.83
09-20 13D/A Fcmi Parent Co. 39.90 30.03

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-08-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-05-15 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-04-25 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A Amendment Number 1
2024-04-02 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)

Similar Companies
UCBJF – UCB SA UNBSF – Uni-Bio Science Group Limited
VAXX – Vaxxinity, Inc. VETOF – Vetoquinol SA
VGLS – VG Life Sciences Inc.


Financial data and stock pages provided by
Fintel.io